The present disclosure includes a medical monitoring hub as the center of monitoring for a monitored patient. The hub includes configurable medical ports and serial ports for communicating with other medical devices in the patient's proximity. Moreover, the hub communicates with a portable patient monitor. The monitor, when docked with the hub provides display graphics different from when undocked, the display graphics including anatomical information. The hub assembles the often vast amount of electronic medical data, associates it with the monitored patient, and in some embodiments, communicates the data to the patient's medical records.

An integrated system for injection including an injection device in electronic connection with a communication device is provided. The external communication device may be a handheld electronic device such as a Smartphone or a dedicated reader such as a reader capable of reading information contained on an RFID tag. The injection device includes a needle and a drug delivery portion enclosed within an external housing. Optionally, a plurality of sensors is affixed to the surface of the needle to collect data about the injection and physical characteristics of the patient. The data may be recorded on a data capture module. The electronic chip may be a readable and writable electronic chip such as a non-volatile memory chip. Alternatively, the electronic chip is a passive RFID tag. The injection device may further include a data transmitter for sending information obtained from the data capture module to the external communications device.

Medical devices coupled to a sensor, and systems including such devices, can generate data and analysis based on that data, which may be used to identify and/or address problems associated with the implanted medical device, including incorrect placement of the device, unanticipated degradation of the device, and undesired movement of the device. Also provided are medical devices coupled to a sensor, and devices and methods to address problems that have been identified with an implanted medical device.

A method and a device for identifying a position of a local coil of a magnetic resonance imaging scanner relative to a position of a patient couch are provided. The device includes at least one reading unit that is configured to determine a position of at least one label at the local coil relative to the at least one reading unit. The device also includes a position determination apparatus that is configured to determine the position of the patient couch relative to the magnetic resonance imaging scanner. The device includes a position determination apparatus that is configured to determine the position of the local coil relative to the patient couch based on the determined position of the at least one label and the determined position of the patient couch.

Methods and systems are provided for automatically configuring a first medical device. In accordance with the methods and the systems, a computing system can obtain prescription information for a patient. The prescription information comprises a device prescription. The computing system can transform the prescription information into first configuration data comprising therapy settings for a first medical device referenced by the device prescription. The computing system can cause automatic configuration of the first medical device based on communicating the first configuration data to the first medical device.

A method that includes configuring a first and a second identification band with unique serial numbers, each of said bands being connected to a signal cable attached to a sensor is provided. The first identification band is securely fixed to a first location on the patient and the second identification band is securely fixed to a second location on the patient. The first and second identification bands are connected with a bridging band. The signal cable is connected to a diagnostic test monitoring system and the patient's oxygen saturation is monitored. The first and second identification bands are configured to evidence tampering when removed.

The invention relates to a device for measuring the temperature in the anus or in the vagina of an animal, wherein a front longitudinal part, an abutment part and a rear longitudinal part lie in succession on the device, wherein the front longitudinal part is equipped with a temperature sensor and, when used as intended, it is intended to be inserted into the anus or the vagina of the animal until the abutment part approximately rests against the outside of the body of the animal. One or more further temperature sensors are attached to the rear longitudinal part and/or to the abutment part, which, when used as intended, are provided for measuring the temperature in the surroundings of the animal.

A nametag transmitter is a nametag transmitter that is to be attached to smartwear including an electrode for detecting biological information, the nametag transmitter including: a reception unit for receiving the biological information from the electrode; a wireless communication unit for transmitting the biological information to a data collection apparatus; a display unit for displaying identification information for specifying a user of the smartwear; and a connection portion to be attached to the smartwear. The nametag transmitter is attached to the smartwear in a state in which pairing between the wireless communication unit and the data collection apparatus has been carried out.

A system includes a plurality of RFID chips affixed to a catheter, a data collection engine device, and a server device. The data collection engine wirelessly transmits power to a first one of the RFID chips and receives first medical data from the first RFID chip while the first RFID chip is activated by the power receiver. The data collection engine generates a first message indicative of the first medical data to be sent to the server device. The server device can determine aspects of the catheter such as position and risk states based upon the first medical data.

The present invention relates to methods for tuning treatment parameters in movement disorder therapy systems. The present invention further relates to a system for screening patients to determine viability as candidates for certain therapy modalities, such as deep brain stimulation (DBS). The present invention still further provides methods of quantifying movement disorders for the treatment of patients who exhibit symptoms of such movement disorders including, but not limited to, Parkinson's disease and Parkinsonism, Dystonia, Chorea, and Huntington's disease, Ataxia, Tremor and Essential Tremor, Tourette syndrome, stroke, and the like. The present invention yet further relates to methods of tuning a therapy device using objective quantified movement disorder symptom data acquired by a movement disorder diagnostic device to determine the therapy setting or parameters to be provided to the subject via his or her therapy device. The present invention also provides treatment and tuning remotely, allowing for home monitoring of subjects.